Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Sponsored by Jaeb Center for Health Research
About this study
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Where this study is enrolling (18)
- I'm interested
University of Alabama at Birmingham
Birmingham, Alabama
- I'm interested
Keck Medical Center of USC
Los Angeles, California
- I'm interested
University of California San Diego
San Diego, California
- I'm interested
Stanford University
Palo Alto, California
- I'm interested
University of Colorado Denver
Aurora, Colorado
Show all 18 locations
- I'm interested
University of Miami
Miami, Florida
- I'm interested
Emory University School of Medicine
Atlanta, Georgia
- I'm interested
University of Iowa
Iowa City, Iowa
- I'm interested
Tulane University
New Orleans, Louisiana
- I'm interested
Massachusetts
Boston, Massachusetts
- I'm interested
University of Minnesota
Minneapolis, Minnesota
- I'm interested
University of New Mexico
Albuquerque, New Mexico
- I'm interested
Columbia University Cystic Fibrosis Program
New York, New York
- I'm interested
Atrium Health Wake Forest Baptist (Wake Forest Baptist)
Winston-Salem, North Carolina
- I'm interested
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
- I'm interested
Medical University of South Carolina
Charlestone, South Carolina
- I'm interested
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
- I'm interested
Baylor College of Medicine
Houston, Texas
Who can participate
Inclusion criteria
- ✓Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative
- ✓For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)
- ✓Be willing and able to adhere to the study protocol requirements
- ✓Age ≥ 12 years at time of enrollment
- ✓CF diagnosis based on two CF causing mutations and/or positive sweat test according to CFF diagnostic criteria
- ✓CFRD diagnosis ≥ 5 years at time of enrollment
Exclusion criteria
- ✕History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject
- ✕History of transplant
- ✕Pregnancy reported by participant at time of consent or at any point during active study participation
- ✕Pulse Wave Velocity Exclusion Criteria:
- ✕Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias
- ✕Carotid or aortic valve stenosis
- ✕Peripheral artery disease or leg artery disease
- ✕Generalized constriction or localized spasm of muscular conduit arteries such as seen immediately after hypothermic cardiopulmonary bypass surgery or accompanying Raynaud's phenomena or intense cold.
- ✕Possible exclusions based on investigator medical provider assessment (additional precautions may be followed to allow inclusion):
- ✕Pressure reading should not be conducted on a limb where there is intravenous access, arterio-venous shunt, or where circulation is compromised.
- ✕Pressure reading should not be conducted on the side of the body that a mastectomy was done.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.